EC
EWTX icon

EcoR1 Capital’s Edgewise Therapeutics EWTX Stock Holding History

EcoR1 Capital’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,250,385
Closed -$33.4M – 64
2024
Q3 		$33.4M Hold
1,250,385
– – 1.14% 23
2024
Q2 		$22.5M Hold
1,250,385
– – 0.69% 31
2024
Q1 		$22.8M Sell
1,250,385
-2,242,809
-64% -$35.6M 0.58% 32
2023
Q4 		$38.2M Hold
3,493,194
– – 0.99% 19
2023
Q3 		$20M Hold
3,493,194
– – 0.68% 29
2023
Q2 		$27.1M Hold
3,493,194
– – 0.66% 20
2023
Q1 		$23.3M Hold
3,493,194
– – 0.75% 21
2022
Q4 		$31.2M Hold
3,493,194
– – 0.95% 19
2022
Q3 		$34.4M Buy
3,493,194
+1,133,386
+48% +$11.5M 1.01% 23
2022
Q2 		$18.8M Hold
2,359,808
– – 0.65% 29
2022
Q1 		$22.9M Buy
2,359,808
+1,080,633
+84% +$13.9M 0.72% 28
2021
Q4 		$19.5M Hold
1,279,175
– – 0.62% 26
2021
Q3 		$21.2M Buy
1,279,175
+55,000
+4% +$995K 0.74% 25
2021
Q2 		$26.1M Hold
1,224,175
– – 0.98% 21
2021
Q1 		$39.8M Buy
+1,224,175
New +$39.7M 1.76% 16

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

EcoR1 Capital's EWTX Position: Q4 2024 in Review

EcoR1 Capital sold out of Edgewise Therapeutics (EWTX) in Q4 2024, closing a stake of 1,250,385 shares — an estimated $33.4M sold.

EcoR1 Capital first reported a position in EWTX in Q1 2021 and held it in 15 quarters. The position peaked at $39.8M in Q1 2021. 200 funds tracked by Wall St. Rank hold EWTX as of Q4 2024.

  • EcoR1 Capital reported no remaining Edgewise Therapeutics position as of Q4 2024 after selling out during the quarter.
  • EcoR1 Capital sold 1,250,385 Edgewise Therapeutics shares in Q4 2024, an estimated $33.4M.
  • EcoR1 Capital first reported a position in Edgewise Therapeutics in Q1 2021 and held it in 15 quarters.
  • EcoR1 Capital's Edgewise Therapeutics position peaked at $39.8M in Q1 2021.
  • 200 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2024.

Based on EcoR1 Capital's 13F filing for Q4 2024, filed 14 Feb 2025.